Welcome to our dedicated page for Akerna news (Ticker: KERN), a resource for investors and traders seeking the latest updates and insights on Akerna stock.
Akerna Corp. (symbol: KERN) is a forward-thinking technology company specializing in software solutions for the cannabis industry. Established in 2010, the company has rapidly grown to become an industry leader, offering comprehensive data and consulting services tailored specifically for cannabis businesses. Akerna's flagship technology, MJ Freeway®, processes over $5 billion in cannabis sales transactions and serves clients across the United States, Canada, Europe, and Australia.
The core of MJ Freeway's offerings is a patented seed-to-sale supply chain ERP platform. This platform leverages sophisticated business intelligence insights to help cannabis businesses manage their operations more efficiently and stay compliant with regulatory requirements. Additionally, MJ Freeway's Leaf Data Systems technology empowers governments to monitor cannabis production and distribution, preventing diversion and ensuring the safety of patients, the public, and products.
In terms of consulting, MJ Freeway offers a complete suite of services designed to assist cannabis businesses in optimizing their operations, from initial setup to scaling their ventures. These consulting services provide expert guidance on navigating the complexities of the cannabis industry, ensuring that businesses are well-positioned for success.
Recently, Akerna has embarked on a series of strategic moves to enhance its market presence. Notably, the company is involved in proposed transactions with Gryphon Digital Mining, Inc. and MJ Acquisition Co. These transactions are expected to close around January 31, 2024, subject to necessary approvals and conditions. Gryphon Digital Mining is a notable player in the Bitcoin space, focusing on integrating digital assets into the clean energy grid with a net carbon-negative strategy.
Financially, Akerna remains committed to managing its operational expenses and navigating the costs associated with these proposed transactions. The company actively engages with investors and stakeholders, providing transparency through regular filings with the U.S. Securities and Exchange Commission (SEC).
For more information about Akerna Corp. and its innovative solutions for the cannabis industry, visit their official website at Akerna.com or contact their Investor Relations department at (516) 419-9915.
Akerna (Nasdaq: KERN) reported its Q2 2022 financial results, highlighting a 33% increase in software revenue to $5.9 million and a 24% rise in total revenue to $6.1 million. The company achieved a gross profit of $4.2 million for a 69.8% margin, up from 60.9% year-over-year. However, Akerna experienced a significant net loss of $29.6 million, influenced by a $24.1 million impairment of long-lived assets. CARR reached $18.9 million, reflecting a 9% growth year-over-year, while cash stood at $14.1 million. The company anticipates material improvements from cost-saving measures in Q3.
Akerna (Nasdaq: KERN) released its annual mid-year review on August 4, 2022, detailing the current state and trends in the cannabis industry. The report emphasizes the industry's resilience against market fluctuations and highlights the importance of technology for growth. Key sections include contributions from CEO Jessica Billingsley and CFO Dean Ditto, discussing financial and operational readiness. It also presents 2022 sales data and ERP insights. The report aims to guide cannabis operators towards successful business maturity and offers projections surrounding future industry growth.
Akerna (Nasdaq: KERN) will report its Q2 2022 financial results after trading on August 10, 2022. A conference call for investors will occur at 8:30 AM ET on August 11, featuring management's remarks and a Q&A session. Established in 2010, Akerna is a leading enterprise software company in the cannabis sector and has tracked over $20 billion in cannabis sales. It provides a robust compliance engine and technology infrastructure for the cannabis industry, including its flagship MJ Platform.
Akerna announces a significant spike in cannabis sales during the Fourth of July weekend, totaling $255.5 million. Notably, Friday, July 1st, recorded $106.7 million in sales, marking it as the second-highest sales day in 2022. This reflects a 19.1% year-over-year increase compared to $89.6 million from the previous year. Akerna's sales data suggests that cannabis is becoming a popular choice for celebrations as legalization spreads across the U.S.
Akerna Corp. (Nasdaq: KERN) has successfully closed its public offering of 29,382,861 units, comprising shares of common stock and common stock warrants, alongside 14,095,400 pre-funded units with associated warrants. The units were priced at $0.23 each, raising approximately $10 million in gross proceeds. The funds will support general corporate purposes, including ongoing debt obligations, marketing, and product development. The offering was managed by A.G.P./Alliance Global Partners, with the registration statement filed with the SEC.
Akerna Corp. (Nasdaq: KERN) has announced a public offering of 29,382,861 units, including common stock and common stock warrants, priced at $0.23 per unit, along with 14,095,400 pre-funded units at $0.2299 each. The gross offering proceeds are expected to be approximately $10 million, with closing around July 5, 2022. Funds will be utilized for general corporate purposes, including debt servicing and product development. The offering includes an underwriters' option for an additional 6,521,739 shares for over-allotments.
Akerna Corp. (Nasdaq: KERN) announced plans to cut its workforce and reduce operating costs to enhance profitability and stakeholder value, effective July 1, 2022. CEO Jessica Billingsley reported a revenue run rate of $27 million and a Contracted Annual Recurring Revenue (CARR) of $21.1 million, highlighting strong bookings. The cost-cutting measures are expected to generate material annual savings, despite anticipated implementation costs of $690,000 for Q2 2022, including severance and legal fees. Akerna aims to focus on its enterprise business and SMB market expansion.
Akerna Corp. (Nasdaq: KERN) held its 2022 annual stockholder meeting on May 25, 2022, where 23,353,671 shares, or approximately 67% of outstanding shares, were represented, fulfilling the quorum requirement.
All director nominees were elected, and stockholders approved several key matters:
- Ratification of Marcum LLP as independent auditors.
- Approval for issuance of shares underlying senior secured convertible notes.
- Authorization to amend the certificate of incorporation to increase shares from 75 million to 150 million.
- Enhancement of the Long Term Incentive Plan by 2.9 million shares.
Akerna Corp. (Nasdaq: KERN) has further adjourned its 2022 annual stockholder meeting to May 25, 2022, at 9 a.m. MT. Stockholders of record as of March 31, 2022 are encouraged to vote by May 24, 2022. Proxies submitted represent approximately 64% of shares, meeting the quorum requirement. While elections for some directors received approval, key proposals for increasing authorized shares and stock incentive plans require further voting. Failure to approve these may lead to liquidity issues for the company.
Akerna (Nasdaq: KERN) announced the engagement of JMP Securities to explore strategic alternatives aimed at maximizing stakeholder value. CEO Jessica Billingsley emphasized their commitment to leveraging business strengths. The company also reported a leadership change, with John Fowle, the current CFO, leaving effective May 17, and Dean Ditto appointed as interim CFO. Ray Thompson will transition from President & COO to Special Advisor to the CEO, continuing to oversee aspects of corporate strategy. The strategic review process may not guarantee any specific outcomes.
FAQ
What is the market cap of Akerna (KERN)?
What is Akerna Corp.?
What is MJ Freeway?
Where does Akerna operate?
What are Akerna's recent achievements?
What consulting services does Akerna offer?
What is Leaf Data Systems?
How does Akerna support regulatory compliance?
What are the details of Akerna's proposed transactions?
How can investors obtain more information?